Gleneagles Hong Kong will become the city’s first hospital network to offer a groundbreaking longevity service that uses artificial intelligence to analyze a patient’s entire genome, epigenetic markers and clinical history from just one blood sample, allowing doctors to predict disease risks and slow biological aging years in advance.
Starting in the first quarter of 2026, the service will be available at Gleneagles Medical Clinic in Central, the Wong Chuk Hang healthcare center, and through the hospital’s teleconsultation platform, with plans to roll it out across the entire network later.
Patients will receive a detailed report combining whole-genome sequencing—which screens for inherited conditions, cancer predispositions, medication responses and polygenic risks for diseases such as Alzheimer’s and hypertension—with an epigenetic assessment that reveals the true biological age of individual organs and how lifestyle, stress and environment are accelerating or slowing aging.
Specially trained physicians will then translate the findings into personalized prevention plans, ranging from dietary changes and exercise recommendations to early medical interventions.
The technology comes from Quantum Life, a Hong Kong-based health-tech company spun off from the InnoHK Quantum AI Lab, and marks Gleneagles’ latest step toward shifting healthcare from treating illness to extending healthy lifespan.
With Hong Kong’s population aging rapidly and growing demand for precision medicine, the partnership aims to set a new standard for preventive care.
By spotting hidden risks long before symptoms appear, the program promises to help people stay healthier for longer through tailored strategies rather than one-size-fits-all advice. Full details and booking information will appear on the Gleneagles website early next year.
